An experimental drug being developed for the treatment of stroke may also prevent Alzheimer’s by preventing the build-up of toxic proteins.
This week we look at gammaCore™ for cluster headache, warnings of stroke risk with a multiple sclerosis drug and a gene therapy for spinal muscular atrophy.
Couldn’t attend the 143rd Annual Meeting of the American Neurological Association? Discover more about the key highlights here.
Couldn’t attend the 11th World Stroke Congress (17–20 October 2018, Montreal, Canada)? Find out more about the key headlines here.
Researchers have revealed that taking a simple test within a week of a stroke may help to predict the long-term prognosis of a patient; this information could be beneficial for patients when making treatment and long-term care decisions.
This week’s industry news round-up reveals the latest updates around spinal muscular atrophy, Parkinson’s disease and acute stroke.
In this International Nurses Day interview, we spoke to Lynn Hundley, current AMWF President, about what led her to become a neuroscience nurse.
In celebration of International Nurses Day, we spoke to Ismalia de Sousa about what inspired her to become a nurse and the challenges present in the field.
Clinical trial announcements, orphan-drug designation and more: check out our round-up of the biggest news from the neuroscience and neurology industries this week.
According to a recent study, an anti-inflammatory drug given to patients in the early stages of a stroke could reduce harmful inflammation.